Risperidone (4 mg tablets): Supply issue resolved
There was a supply issue affecting Risperidone (Teva) tablets 4 mg presentation.
Affected product
There was a supply issue affecting:
| Chemical | Brand | Presentation | Pharmacode | Subsidy | Measure/Qty |
|---|---|---|---|---|---|
| Risperidone | Risperidone (Teva) | Tab 4 mg | 2466937 | $6.25 | per 60 |
Schedule listing: Risperidone(external link)
Alternative: two x 2 mg tablets
We advised that two x 2 mg risperidone tablets can be used as an alternative where a 4 mg is not available.
| Chemical | Brand | Presentation | Pharmacode | Subsidy | Measure/Qty |
|---|---|---|---|---|---|
| Risperidone | Risperdal | Tab 4 mg | 245402 | $6.25 | per 60 |
Medsafe datasheet for Risperdal(external link)
The oral liquid is also available in significant quantities. However, people would need a new prescription.
We listed other brands and strengths to support earlier supply issues affecting risperidone.
- Risperidone Supply issue (Oct 24) A5 flier [PDF 197 KB]
Resupplied September 2025
Teva has released stock of its 4 mg risperidone product.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)